Back to search
FDAFDA · Food and drugs·Recall number D-0164-2017

Ondansetron HCI API, Bulk, Manufacturer: Cadila Pharmaceuticals, Ltd., Ankleshwar, Gujarat, India 393002

Published December 7, 2016 · Recall initiated: September 9, 2016

Summary

FDA records drug Class II recall D-0164-2017, published December 7, 2016 and initiated September 9, 2016. Recalling firm: Cadila Pharmaceuticals Limited; Status: Terminated; Reported quantity: 6.0kg; Lot: Supplied Batch, 150N004; Exp. 08/20 Supplied Batch, 150N006; Exp. 09/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Product

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cadila Pharmaceuticals Limited
Distributor
According to the firm, the API distributed to two consignees in the US. See Consignee list below. Consignee List: 1). LLC LENS Phanna. Russia 2). Claris irljectable, Ahmedabad 3). CPL. Inc, USA
Lot
Supplied Batch, 150N004; Exp. 08/20 Supplied Batch, 150N006; Exp. 09/20
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Ondansetron HCI API, Bulk, Manufacturer: Cadila Pharmaceuticals, Ltd., Ankleshwar, Gujarat, India 393002 recalled?

Yes. FDA published recall D-0164-2017 on December 7, 2016. Reported hazard: Microbial Contamination of Non-Sterile Product

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail